| Â | GI | GII | GIII |
|---|
|  | IncB (μg/ml) | IncC (μg/ml) | IncB (μg/ml) | IncC (μg/ml) | IncB (μg/ml) | IncC (μg/ml) |
|---|
| Â | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 | 0.5 | 1 |
|---|
Cervical cells
|
111
(48–214 |
126
(67–263) |
91
(29–167) |
142
(43–211) |
132
a
(47–312) |
157
b
(56–343) |
112
c
(38–112) |
178
d
(77–329) |
43
(12–59) |
49
(12–88) |
38
(17–63) |
59
(26–76) |
PBMCs
|
121
(38–200) |
134
(45–212) |
103
(48–176) |
172
(44–176) |
212
a
(56–273) |
226
b
(76–301) |
243
c
(91–322) |
251
d
(100–316) |
56
(38–97) |
67
(43–115) |
63
(59–108) |
81
(60–149) |
- Note. Median number of IFN-γ SFCs per 7.5 × 104 CD4+ T cells at 18 h post stimulation with IncB or IncC (0.5 μg/ml and 1 μg/ml) counted using ELISPOT. Figures in parenthesis depict range of SFCs for each group.
- a, b, c, d P < 0.05 Number of IFN-γ in GII compared to respective levels in group III by Mann Whitney U test where, Group I (GI) comprised of healthy fertile women with no CT infection, Group II (GII) comprised of CT-positive fertile women.
- Group III (GIII) comprised of CT-positive women with fertility disorders.
- IncB- CT Inclusion membrane protein B; IncC- CT Inclusion membrane protein C; CT- Chlamydia trachomatis; EB-Elementary bodies; IL-Interleukin; IFN-γ-Interferon gamma; SFCs-Spot forming cells.
